Panjon Peer Comparison

Panjon Ltd. shows significant weaknesses in growth and profitability metrics compared to its peers in the Pharmaceuticals & Drugs sector. While it has a low debt-to-equity ratio, its revenue growth and profitability measures are poor, positioning it as an underperformer. Companies like Cipla Ltd. and Dr. Reddy's Laboratories Ltd. demonstrate stronger profitability and growth, making them sector leaders.

• • Panjon Ltd. has negligible revenue growth and low profitability metrics.
• • Cipla Ltd. and Dr. Reddy's Laboratories Ltd. show the best profitability and growth metrics.
• • Sun Pharmaceutical Industries Ltd. and Divi's Laboratories Ltd. are on the higher end of valuation ratios but have strong returns.

• • Cipla Ltd.: Strong revenue growth (13.28% YoY) and low PE ratio of 23.73, indicating both profitability and valuation attractiveness.
• • Dr. Reddy's Laboratories Ltd.: High ROE (21.76%) and low PE (15.50), showing excellent returns and reasonable valuation.
• • Mankind Pharma Ltd.: Highest revenue growth (18.12% YoY) and solid profitability metrics, making it a strong contender.